| Economics and Finance | Lifetime | 546 | — | 99.62 |
| Economics and Finance | 2021-2025 | 523 | — | 98.05 |
| Econometrics and Quantitative Economics | Lifetime | 304 | — | 99.67 |
| Oncology | Lifetime | 292 | — | 99.52 |
| Toxicology | Lifetime | 354 | — | 74.74 |
| Oncology | 2021-2025 | 148 | — | 98.91 |
| Econometrics and Quantitative Economics | 2021-2025 | 380 | — | 98.03 |
| Public, Environmental and Occupational Health | 2021-2025 | 640 | — | 93.96 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 759 | — | 90.23 |
| Cancer survivorship and care | Lifetime | 14 | — | 99.77 |
| Economic and Financial Impacts of Cancer | Lifetime | 13 | — | 99.66 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 105 | — | 99.59 |
| Clinical practice guidelines implementation | Lifetime | 34 | — | 99.39 |
| Childhood Cancer Survivors' Quality of Life | Lifetime | 165 | — | 98.99 |
| Palliative Care and End-of-Life Issues | Lifetime | 174 | — | 98.91 |
| Patient-Provider Communication in Healthcare | Lifetime | 83 | — | 98.78 |
| Cancer Treatment and Pharmacology | Lifetime | 341 | — | 98.99 |
| Prostate Cancer Treatment and Research | Lifetime | 495 | — | 98.59 |
| Nausea and vomiting management | Lifetime | 195 | — | 97.30 |
| Ethics in Clinical Research | Lifetime | 309 | — | 95.03 |
| Statistical Methods in Clinical Trials | Lifetime | 363 | — | 95.76 |
| Advances in Oncology and Radiotherapy | Lifetime | 416 | — | 92.92 |
| Patient Satisfaction in Healthcare | Lifetime | 665 | — | 93.96 |
| Cancer-related cognitive impairment studies | Lifetime | 359 | — | 92.86 |
| Pain Management and Opioid Use | Lifetime | 858 | — | 92.96 |
| Pharmacovigilance and Adverse Drug Reactions | Lifetime | 438 | — | 89.73 |
| Meta-analysis and systematic reviews | Lifetime | 946 | — | 90.19 |
| Food Science and Nutritional Studies | Lifetime | 713 | — | 76.52 |
| Medicinal Plant Extracts Effects | Lifetime | 873 | — | 52.53 |
| Cancer survivorship and care | 2021-2025 | 8 | — | 99.48 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 23 | — | 98.60 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 200 | — | 97.74 |
| Palliative Care and End-of-Life Issues | 2021-2025 | 217 | — | 96.31 |
| Cancer-related cognitive impairment studies | 2021-2025 | 64 | — | 93.62 |
| Cancer Treatment and Pharmacology | 2021-2025 | 361 | — | 92.64 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 609 | — | 91.57 |
| Statistical Methods in Clinical Trials | 2021-2025 | 203 | — | 88.41 |
| Neutropenia and Cancer Infections | 2021-2025 | 312 | — | 82.65 |
| Clinical practice guidelines implementation | 2021-2025 | 605 | — | 73.23 |